adamantane has been researched along with calcitriol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DeLuca, HF; Igarashi, M; Ishizawa, M; Makishima, M; Shimizu, M; Yamada, S; Yamamoto, K; Yoshimoto, N | 1 |
| Ikura, T; Ishizawa, M; Ito, N; Makishima, M; Mouriño, A; Tokiwa, H; Uno, S; Watarai, Y; Yamada, S; Zacconi, FC | 1 |
2 other study(ies) available for adamantane and calcitriol
| Article | Year |
|---|---|
Identification of a highly potent vitamin D receptor antagonist: (25S)-26-adamantyl-25-hydroxy-2-methylene-22,23-didehydro-19,27-dinor-20-epi-vitamin D3 (ADMI3).
Topics: Adamantane; Animals; Calcitriol; Chlorocebus aethiops; COS Cells; Models, Molecular; Molecular Conformation; Rats; Receptors, Calcitriol; Transcription, Genetic | 2007 |
Synthesis, Biological Activities, and X-ray Crystal Structural Analysis of 25-Hydroxy-25(or 26)-adamantyl-17-[20(22),23-diynyl]-21-norvitamin D Compounds.
Topics: Adamantane; Calcitriol; Cell Line, Tumor; Crystallography, X-Ray; Drug Partial Agonism; HEK293 Cells; Humans; Molecular Structure; Organ Specificity; Receptors, Calcitriol; Stereoisomerism; Structure-Activity Relationship; Transcriptional Activation | 2015 |